The Biden administration’s claims about the treatment of gender dysphoria in children were disputed this week by Florida’s Dept. of Health, which released information that stated puberty blockers and cross-sex hormones should not be given to treat gender dysphoria in youngsters.
The instructions were released as a heated national debate regarding the best therapy for kids that identify as transgender rages on. A contentious law passed in Alabama this year makes it a crime to administer or prescribe puberty blockers or cross-sex hormones to people under the age of 19, and has already been challenged in court. In Texas, a judge halted an order signed by Republican Gov. Greg Abbott that likened transgender therapy to “child abuse” and ordered the state agencies to investigate healthcare providers who provide such treatments as criminals.
In a statement on “Transgender Day of Visibility,” Biden slammed the “avalanche” of anti-transgender state laws and advised parents that praising their child’s identity is one of the most effective ways to keep them safe.
Significant discomfort felt by a person when their sex or gender assigned at birth does not correspond to their identity is described in the clinical definition of gender dysphoria.
According to the Florida Department of Health, “the current evidence does not suggest that puberty blockers, hormone therapy, or surgical procedures are beneficial for kids and adolescents who are experiencing gender dysphoria.” According to research published in the International Review of Psychiatry, 80 percent of individuals that identify as transgender and get clinical care will lose their motivation to identify with their birth sex.
The department added that pubertal maturity is crucial for brain development, and scientific evidence indicates that the part of the brain responsible for decision-making isn’t completely developed until age 25. The department also warned of “potentially irreversible consequences such as cardiovascular disease, osteoporosis, infertility, an increased cancer risk, and thrombosis” from puberty blockers and cross-sex hormone treatments.
The American College of Pediatricians (ACP) claims that social gender transition, puberty blockers, and cross-sex hormones have “an unacceptably high risk of causing trauma” to children.
Florida’s advice takes aim at federal guidelines and the views of renowned medical organizations.
In a series of statements last month in response to steps taken by Republican-controlled state governments, the Biden administration backed sex-change operations and cross-sex hormone therapies for gender dysphoric kids. The Department of Health and Human Services argued that “gender-affirming care” is the “normal of care for transgender, gender diverse, and intersex children,” as defined by “leading medical organizations,” including the American Medical Association, American Psychiatric Association, and American Academy of Pediatrics.